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The NLRP3 inflammasome is an important compo-
nent of the innate immune system. However, its
mechanism of activation remains largely unknown.
We show that NLRP3 activators including bacterial
pore-forming toxins, nigericin, ATP, and particulate
matter caused mitochondrial perturbation or the
opening of a large membrane pore, but this was not
required for NLRP3 activation. Furthermore, reactive
oxygen species generation or a change in cell volume
was not necessary for NLRP3 activation. Instead, the
only common activity induced by all NLRP3 agonists
was the permeation of the cell membrane to K+ and
Na+. Notably, reduction of the intracellular K+ con-
centration was sufficient to activate NLRP3, whereas
an increase in intracellular Na+ modulated but was
not strictly required for inflammasome activation.
These results provide a unifying model for the activa-
tion of the NLRP3 inflammasome in which a drop in
cytosolic K+ is the common step that is necessary
and sufficient for caspase-1 activation.
INTRODUCTION
Amajor signaling pathway of the innate immune system is the in-
flammasome, a multiprotein platform that activates caspase-1
(Schroder and Tschopp, 2010). Once activated, caspase-1
proteolytically processes several protein substrates including
pro-interleukin-1b (pro-IL-1b) and pro-IL-18 into their biologi-
cally active forms. To date, four inflammasomes have been
described, of which three inflammasomes —the NLRP1,
NLRP3, and NLRC4—contain a PRR that belongs to the intracel-
lular Nod-like receptor (NLR) family (Franchi et al., 2012). Among
the NLR inflammasomes, NLRP3 has been under intense inves-
tigation given its link to inherited autoinflammatory syndromes
(Hoffman et al., 2001) and to several acquired inflammatory dis-
orders (Wen et al., 2012). Activation of the NLRP3 inflammasome
ismediated by two signals. The first signal, referred as priming, is
the NF-kB-dependent transcription of NLRP3 and pro-IL-1b,1142 Immunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc.through stimulation with Toll-like receptor (TLR) agonists or
certain cytokines such as tumor necrosis factor-a (TNF-a) or
IL-1b (Bauernfeind et al., 2009; Franchi et al., 2009). The second
signal activates NLRP3 and is induced by nigericin, ATP, bacte-
rial pore-forming toxins (PFTs), or crystalline and particulate
matter (Hornung et al., 2008; Mariathasan et al., 2006). However,
how these structurally unrelated stimuli activate NLRP3 remains
unclear.
Several events have been proposed to explain the activation of
the NLRP3 inflammasome including the production of reactive
oxygen species (ROS), mitochondrial damage, lysosomal dam-
age, formation of large nonspecific pore in the cell membrane,
and cytosolic K+ efflux (Franchi et al., 2012). The identification
of the cellular event responsible for NLRP3 activation is compli-
cated by the fact that NLRP3 activators trigger multiple cellular
signals. The paradigm to explain this complexity has been
ATP, which causes all the aforementioned cellular events, that
is, opens a large pore permeable to monovalent cations and
molecules up to 900 Da (Steinberg et al., 1987), increases the
production of ROS (Cruz et al., 2007), and damages several
organelles including the mitochondria and lysosomes (Lopez-
Castejon et al., 2010; Shimada et al., 2012). Furthermore, mem-
brane permeation, lysosomal damage, mitochondrial damage,
and ROS production are interrelated cellular events (Guicciardi
et al., 2004), complicating even further the distinction between
bystander and causative events of NLRP3 activation. The objec-
tive of this study was to identify the cellular signal responsible for
NLRP3 activation in response to diverse stimuli. For that
purpose, we analyzed and compared the cellular effects
caused by NLRP3 activators, including mitochondrial perturba-
tion, ROS generation, change in cell volume, and membrane
permeability to organic molecules and ions in order to define
theminimal requirement(s) to trigger NLRP3. Our results suggest
a unifying model for NLRP3 activation induced by various stimuli
in which K+ efflux is the intracellular event that triggers NLRP3
activation.
RESULTS
Mitochondrial Perturbation Is Not Required for NLRP3
Activation
Mitochondrial damage has been implicated in NLRP3 activation;
therefore, we analyzed mitochondrial function in response to the
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Figure 1. Mitochondrial Perturbation Is not
Required to Activate NLRP3
(A) LPS-primed WT and Nlrp3/ BMDMs were
stimulated for 30 min with 10 mM nigericin (Nig) or
0.5 mM gramicidin (Gra), and supernatants were
analyzed for IL-1b by ELISA.
(B) Effect of nigericin (10 mM, Nig) and gramicidin
(0.5 mM, Gra) on mitochondrial function. Oxygen
consumption rate (OCR) and extracellular acidifi-
cation rate (ECAR) were measured in BMDMs.
Black arrows indicate the time of addition of the
stimuli.
(C and D) BMDMs were treated for 30 min with
nigericin (10 mM, Nig) or gramicidin (0.5 mM, Gra),
and the intracellular levels of ATP (C) and lactate
(D) were determined.
(E) Role of Na+/K+-ATPase in mitochondrial
perturbation by gramicidin. OCR and ECAR trig-
gered by the addition of 0.5 mM gramicidin (Gra)
were measured in the absence (upper panels) and
presence (lower panels) of 125 mM ouabain (Oua).
Black arrows indicate the time of addition of
gramicidin.
(F) LPS-primed WT and Nlrp3/ BMDMs were
treated for 15minwith 0.5 mMgramicidin or vehicle
in the presence or absence of 125 mM ouabain
(Oua) and changed to their respective medium
without gramicidin for an additional 15 min. IL-1b
was measured in supernatants (left panel) and
caspase-1 in cell extracts by immunoblotting (right
panel).
(G) BMDMswere stimulated for 15min or 60min with 0.5 mMgramicidin or left untreated in the presence of 125 mMouabain (Oua), and themitochondrial function
was evaluated immediately after by performing a bioenergetic profile. Vertical lines indicate the injection of the specified mitochondrial inhibitors. Values
represent mean ± SD (n = 3–4). Results are representative of at least three separate experiments. NS, not statistically significant (pR 0.05). *p < 0.05. See also
Figure S1.
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K+ Efflux Activates NLRP3NLRP3 agonists nigericin and gramicidin (Figure 1A; Allam et al.,
2011; Mariathasan et al., 2006). We monitored mitochondrial
function in real-time during stimulation with the NLRP3 agonists
by measuring the O2 consumption rate (OCR) and the extracel-
lular acidification rate (ECAR). To ensure that the measured
changes in mitochondrial function are upstream to NLRP3 and
are not secondary to caspase-1 activation, we performed all
the bioenergetics studies inNlrp3/macrophages unless other-
wise specified. Both nigericin and gramicidin caused a rapid
increase in OCR and ECAR in BMDMs (Figure 1B). Nigericin,
however, caused a much greater increase in ECAR than
gramicidin (Figure 1B). Furthermore, treatment with nigericin,
but not with gramicidin, led to a significant decrease in the intra-
cellular pool of ATP and an increase in lactate concentrations
(Figures 1C and 1D). These results suggest that although both
nigericin and gramicidin are robust activators of NLRP3, grami-
cidin causes much less mitochondrial perturbation than nigeri-
cin. Thus, we sought to further understand the effects of
gramicidin on the mitochondria to elucidate whether mitochon-
drial perturbation is required for the activation of the NLRP3
inflammasome.
Gramicidin forms pores in lipid bilayers that are permeable to
monovalent cations and H2O, collapsing the transmembrane
gradient of Na+ and K+ in treated cells (Andersen et al., 2005).
Therefore, we hypothesized that the rapid rise in the OCR trig-
gered by gramicidin is secondary to an increase in energy con-
sumption caused by the activation of the Na+- and K+-ATPase.Treatment of BMDMs with ouabain, an inhibitor of the Na+-
and K+-ATPase, did not alter the basal amounts of the OCR
and ECAR (Figure 1E). However, ouabain abolished the increase
in the OCR and ECAR triggered by gramicidin (Figure 1E) without
impairing its ability to activate NLRP3 (see Figure S1A available
online). Similar to gramicidin, the NLRP3 agonist ATP, by acting
on the P2x7 receptor (P2rx7), permeates the cell membrane and
collapses cation gradients (Surprenant et al., 1996). Consis-
tently, ATP also elicited a rapid increase in the OCR, which
was inhibited by ouabain (Figure S1B) and absent in P2rx7/
BMDMs (Figure S1C). To exclude the possibility that the
observed inhibition in mitochondrial function by ouabain is due
to off-target effects, we also inhibited the Na+- and K+-ATPase
by culturing the cells in K+-free medium because the enzyme
cannot function in the absence of extracellular K+ (Rose and
Ransom, 1997). Like ouabain, media lacking K+ did not change
the basal OCR and ECAR but completely blocked the increase
in the OCR and ECAR triggered by gramicidin (Figure S1D).
Collectively, these results suggest that the effect of gramicidin
on mitochondrial function as observed by increases in the
OCR and ECAR is indirect and caused by the activation of the
Na+- and K+-ATPase. Consistently, inhibition of the Na+- and
K+-ATPase prevented gramicidin-induced changes in the OCR
and ECAR but did not impair the ability of gramicidin to activate
NLRP3.
Gramicidin can also perturb the mitochondria directly by
permeating the mitochondrial membranes. To explore thisImmunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc. 1143
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Figure 2. ROS Production Is Not Required
to Activate NLRP3
(A) LPS-primed WT and Nlrp3/ BMDMs were
stimulated for 6 hr with 10 mM rotenone, 10 mg/ml
antimycin A, 10 mM 3-methyladenine (3-MA), or
1 mM H2O2, or treated 30 min with 0.5 mM of
gramidicin. NLRP3 activation was detected by
measuring the secretion of IL-1b (upper panel) and
caspase-1 activation (lower panel).
(B) CM-H2DCFDA-labeled BMDMs were incu-
bated in medium containing ROS scavengers
N-acetyl-L-cysteine (NAC, 2.5 mM), N-(2-Mer-
captopropionyl)glycine (MPG, 2.5 mM), and
ascorbic acid (AA,150 mM). The oxidation of
CM-H2DCFDA was measured (upper panel) and
the oxidation rate was calculated (lower panel).
(C) The effect of ROS scavengers on signal 1 and
signal 2 of NLRP3 activation induced by gramicidin
was evaluated. WT BMDMs were primed with LPS
for 3 hr in the presence of ROS scavengers and
subsequently stimulated with 0.5 mM gramicidin
(signal 1) or primed for 3 hr with LPS and stimu-
lated with gramicidin in the presence of ROS
scavengers (signal 2). NLRP3 activation was
assessed by measuring IL-1b release (upper
panel) and caspase-1 activation (lower panel).
(D) BMDMs labeled with the fluorescent ROS
probe CM-H2DCFDA were stimulated with 0.5 mM
gramicidin (Gra), 1 mM H2O2, or medium. The
oxidation of CM-H2DCFDA was monitored (upper
panel) as in (B), and the oxidation rate was calcu-
lated (lower panel).
(E) LPS-primed WT BMDMs were stimulated with
nigericin (10 mM, Nig), gramicidin (0.5 mM, Gra), or
5 mM ATP for 30 min with the indicated amount of
NAC, and caspase-1 activation was analyzed.
(F and G) LPS-primed WT (F) and Nlrp3/ (G)
BMDMs were stimulated with nigericin (10 mM,
Nig), gramicidin (0.5 mM, Gra), or ATP (5 mM) for
30 min, with Salmonella (MOI 10, Sal) for 1 hr or
with pdAdT (5 mg/ml) for 4 hr in the presence of the
indicated amounts of DPI. Caspase-1 activation (F) and the intracellular content of K+ (G) were measured. Caspase-1 activation was analyzed by immunoblotting
and IL-1b by ELISA. Cells were treated for 30 min with the inhibitors or medium before adding the agonists. The intracellular levels of K+ were quantified by
ICP-OES inNlrp3/ cells. Values represent mean ± SD (n = 3–4). Results are representative of at least three separate experiments. NS, not statistically significant
(pR 0.05). *p < 0.05 (stimulated versus unstimulated).
Immunity
K+ Efflux Activates NLRP3possibility, we studied the effect of gramicidin on the coupling
efficiency and the maximal respiratory capacity of BMDMs by
performing bioenergetic profiles. For this purpose, macro-
phages were first stimulated with gramicidin, and the OCR
was monitored while we sequentially administered the mito-
chondrial inhibitors oligomycin, FCCP, and rotenone. To
demonstrate that the inhibitors were used at maximally effec-
tive doses, we consecutively stimulated BMDMs twice with
the same dose of inhibitor (Figure S1E). Importantly, stimula-
tion of BMDMs with 0.5 mM gramicidin for 15 min resulted in
NLRP3 activation (Figure 1F) without affecting mitochondrial
function (Figure 1G). Longer stimulation with gramicidin
(60 min), however, led to mitochondrial damage demonstrated
by the uncoupling of the oxidative phosphorylation and a
decrease in themaximal respiratory capacity (Figure 1G). Collec-
tively, these results demonstrate that perturbation of and
damage to the mitochondria that can occur with NLRP3
activators are not necessary events to activate the NLRP3
inflammasome.1144 Immunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc.ROS Production Is Not Necessary for NLRP3 Priming or
Activation
ROS generation resulting from mitochondrial damage has been
implicated in NLRP3 activation (Zhou et al., 2011). Unlike this
study, we could not detect NLRP3 activation following stimula-
tion with the mitochondrial toxicants rotenone and antimycin A,
the autophagy inhibitor 3-methyladenine, or H2O2 (Figure 2A).
To further clarify the role of ROS in NLRP3 activation, we studied
the effect of the ROS scavengers N-acetyl-L-cysteine (NAC),
ascorbic acid (AA), and N-(2-Mercaptopropionyl)glycine (MPG)
on priming (signal 1) and NLRP3 activation (signal 2) in response
to gramicidin. By using concentrations of ROS scavengers that
had a profound inhibitory effect on the cellular redox state (Fig-
ure 2B), we found no effect of these inhibitors on either the prim-
ing or activation of the NLRP3 inflammasome (Figure 2C). In
addition, treatment with gramicidin did not lead to an increase
in ROS production (Figure 2D). High concentrations of NAC
have been reported to inhibit NLRP3 activation (Cruz et al.,
2007). However, we did not observe this effect by using NAC
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Figure 3. Phagocytosis of Particulate
Matter Triggers K+ Efflux and Activates
NLRP3
(A and B) LPS-primed WT and Nlrp3/ BMDMs
were treated for 30 min with 10 mM nigericin (Nig),
0.5 mM gramicidin (Gra), 10 mg/ml S. aureus
a-hemolysin (aH), 10 ng/ml A. hydrophila aerolysin
(Aero), or 5 mM ATP. Secreted IL-1b (A) and the
intracellular content of K+ (B) were measured.
(C) LPS-primed WT and Nlrp3/ BMDMs were
stimulated with 250 mg/ml of Al(OH)3, silica (SiO2)
or calcium pyrophosphate crystals (CPPD), or with
1 mM L-leucyl-L-leucine methyl ester (LL-OMe),
and secreted IL-1b and the intracellular content of
K+ were determined at the specified time points.
(D–F) Effect of inhibition of phagocytosis in K+
efflux and NLRP3 activation caused by particulate
matter and LL-OMe. LPS-primedWT andNlrp3/
BMDMs were incubated for 30 min with phago-
cytosis inhibitors cytochalasin B (Cyt B, 5 mM) or
latrunculin B (Lat B, 200 nM) and subsequently
treated with 250 mg/ml of Al(OH)3, silica (SiO2) or
CPPD, or with 1 mM LL-OMe. The intracellular
content of K+ (D) and IL-1b release in WT and
Nlrp3/ BMDMs (E) were measured. K+ de-
terminations were performed by ICP-OES in
Nlrp3/ cells. Values represent mean ± SD (n = 3).
Results are representative of at least three sepa-
rate experiments. Asterisks (*) indicate NLRP3
activation (p < 0.05, WT versus Nlrp3/). Crosses
( 3 ) indicate a drop in intracellular content of K+
(p < 0.05, stimulated versus nonstimulated). See
also Figure S2.
Immunity
K+ Efflux Activates NLRP3at neutral pH (Figure 2E). Similarly, the NAPDH inhibitor DPI did
not impair caspase-1 activation at 10 mM (Figure 2F), a concen-
tration that causes maximal NAPDH inhibition (Decleva et al.,
2006). At a concentration 10 times higher, DPI prevented cas-
pase-1 activation without altering the efflux of K+ (Figures 2F
and 2G). However, 100 mM DPI also impaired the activation of
the NLRC4 and the AIM2 inflammasome (Figure 2F). Thus,
ROS do not play a role in NLRP3 activation.
Phagocytosis of Particulate Matter Triggers K+ Efflux
and NLRP3 Activation
A role of K+ efflux in NLRP3 activation has been proposed
because several NLRP3 activators can permeate the cell mem-
brane to K+ (Figures 3A and 3B; Perregaux and Gabel, 1994)
and increasing the extracellular [K+] inhibits inflammasome acti-
vation by all tested NLRP3 activators (Pe´trilli et al., 2007). How-
ever, particulate matter has not been reported to trigger the
efflux of K+, and there is no evidence that reduction of cytosolic
[K+] alone is sufficient to trigger NLRP3 activation. Therefore, we
studied whether NLRP3 activators that have been proposed to
act via lysosomal damage, i.e., particulate matter and the lyso-
somal-damaging dipeptide LL-OMe (Hornung et al., 2008), also
cause efflux of K+. To establish a reliable correlation between
intracellular K+ concentrations and NLRP3 activation, we
measured IL-1b release and K+ efflux in parallel. We determined
K+ concentrations inNlrp3/macrophages because caspase-1
activation can lead to pyroptosis and nonspecific membrane
permeation (Figure S2A). Time-course experiments revealed
that a drop in the intracellular content of K+ preceded the releaseof IL-1b induced by Al(OH)3, silica, calcium pyrophosphate crys-
tals (CPPD), and LL-OMe (Figure 3C). Phagocytic uptake is also
a requirement for NLRP3 activation induced by particulate
matter (Hornung et al., 2008; Martinon et al., 2006). Therefore,
we investigated a role for phagocytosis in K+ efflux elicited by
particulate NLRP3 activators. Pretreatment of BMDMs with the
phagocytosis inhibitors cytochalasin B and latrunculin B strongly
impaired both the efflux of K+ (Figure 3D) and NLRP3-dependent
IL-1b secretion triggered by particulate matter (Figure 3E), but
not by LL-OMe (Figures 3D and 3E). We did not observe any
difference in K+ efflux caused by NLRP3 agonists among WT
and Nlrp3/ unprimed BMDMs (Figures S2B). However, we
observed a major effect of LPS priming on K+ efflux caused
by particulate matter and LL-OMe. Specifically, LPS priming
enhanced K+ efflux caused by SiO2, Al(OH)3, CPPD crystals,
and LL-OMe, but not by nigericin, gramicidin, and ATP (Fig-
ure S2C; data not shown). These findings are consistent with a
role of phagocytosis and pinocytosis in the uptake of these
stimuli (Figure 3D) because LPS treatment has been shown to
enhance both processes (Chen et al., 2012; Peppelenbosch
et al., 1999).
The lysosomal inhibitors Ca-074 Me and Bafilomycin A pre-
vent NLRP3 activation induced by particulate matter, but not
ATP (Hornung et al., 2008). In accord with these results, Ca-
074 Me and Bafilomycin A prevented K+ efflux and NLRP3 acti-
vation triggered by particulate matter and LL-OMe (Figures S2D
and S2E), but not by nigericin or ATP (data not shown). However,
IL-1b release was not impaired in cathepsin B-deficient BMDMs
(Figure S2F), suggesting that the inhibition by Ca-074 Me is dueImmunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc. 1145
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K+ Efflux Activates NLRP3to off-target effects. Alternatively, Ca-074 Me could be targeting
another cathepsin or multiple cathepsins that are responsible
for membrane permeation following the uptake of particulate
matter.
Extracellular Ca2+ Activates NLRP3 through K+ Efflux
Lee et al. have recently proposed that calcium signaling plays a
crucial role in NLRP3 activation (Lee et al., 2012). The authors
showed that high extracellular Ca2+ activates NLRP3 in RPMI
medium.We found that NLRP3 activation by Ca2+ was abolished
by high extracellular K+ (Figure S2G) and correlated with a
decrease in the intracellular amounts of K+ (Figure S2H). Further-
more, we found that high extracellular Ca2+ causes K+ efflux and
NLRP3 activation in RPMI medium, but not in IMDM, DMEM, or
HBSS (Figure S2I). However, gramicidin causes K+ efflux and
NLRP3 activation in all testedmedia (Figure S2I). The concentra-
tion of PO4
3 in RPMI is significantly higher than that in IMDM,
DMEM, and HBSS, and calcium phosphate salts are insoluble
in aqueous medium and can activate NLRP3 (Jin et al., 2011).
We noticed that the addition of Ca2+ to RPMI leads to the forma-
tion of particulate matter (Figure S2J). On the contrary, addition
of either Ca2+ or PO4
3 to IMDM did not cause any particulate
precipitation (Figure S2J). However, when IMDM was supple-
mented with both Ca2+ and PO4
3, particulate matter was
formed (Figure S2J), which correlated with K+ efflux and
NLRP3 activation that was inhibited by high extracellular K+ (Fig-
ure S2K). These results suggest that high extracellular Ca2+
activates NLRP3 acting as particulate matter, i.e., triggering K+
efflux. The CASR agonist R-568 and the PLC activator
m-3M3FBS have also been reported to activate NLRP3 (Lee
et al., 2012). We could detect NLRP3 activation by m-3M3FBS,
but not R-568 (Figure S2L). Notably, caspase-1 activation by
m-3M3FBS was inhibited by high extracellular K+ (Figure S2L).
K+ Efflux Is a Specific Upstream Requirement for the
Activation of the NLRP3 Inflammasome
AIM2 recognizes cytosolic double-stranded DNA and activates
caspase-1, which was found to be inhibited by concentrations
of extracellular K+ higher than 60 mM (Fernandes-Alnemri
et al., 2010). Given the potential toxic effects of very high extra-
cellular K+ concentrations, we determined the extracellular [K+]
sufficient to prevent NLRP3 activation by nigericin, bacterial
PFTs, ATP, particulate matter, and LL-OMe. Increasing the
extracellular [K+] from 5 to 30 mM had a major inhibitory effect
on NLRP3 activation by all tested stimuli (Figures 4A and 4B).
Furthermore, increasing the extracellular [K+] from 30 to 45 mM
had a minor or no additional inhibitory effect on NLRP3 activa-
tion, and raising it from 45 to 60 mM did not have any additional
inhibitory effect for any of the stimuli (Figures 4A and 4B). Thus,
an extracellular [K+] of 45 mM provides maximal inhibition of
NLRP3 activation by all activators tested.
Activation of AIM2 is associated with recruitment of the bipar-
tite adaptor Asc, leading to its oligomerization and the activation
of caspase-1 (Fernandes-Alnemri et al., 2010). Consistent with
this study, IL-1b secretion induced by the AIM2 activator
polydAdT was totally dependent on Asc, but independent of
NLRP3 (Figure 4C). Unlike gramicidin, stimulation with polydAdT
did not elicit a decrease in the intracellular content of K+ (Fig-
ure 4D). Furthermore, IL-1b secretion triggered by polydAdT1146 Immunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc.was not inhibited by an extracellular [K+] of 45 mM, which effec-
tively blocked gramicidin-induced IL-1b secretion (Figure 4E).
Collectively, these results indicate that the efflux of K+ is specific
to NLRP3 activation and does not play a role in the activation of
the AIM2 inflammasome.
NLRP3 also requires the adaptor Asc to activate caspase-1
(Mariathasan et al., 2004). Similar to ATP (Juliana et al., 2010),
gramicidin elicited Asc oligomerization and its migration to the
detergent-insoluble protein fraction in cellular extracts (Fig-
ure 4F). Asc oligomerization was inhibited by 45mMextracellular
K+ (Figure 4F), suggesting that K+ regulates the NLRP3 inflam-
masome by acting upstream of caspase-1. To better define the
step in the NLRP3 inflammasome signaling pathway regulated
by K+, we analyzed the role of K+ in caspase-1 activation in
BMDMs harboring theNlrp3R258Wmutation. Thismutation corre-
sponds to the R260W mutation in human NLRP3, which is
associated with Muckle-Wells syndrome. In agreement with a
previous study (Meng et al., 2009), treatment of Nlrp3R258W
BMDMs with LPS alone was sufficient to activate caspase-1
and was blocked by the caspase-1 inhibitor YVAD (Figures 4G
and 4H). However, caspase-1 activation elicited by LPS was
not inhibited bymedia containing 45mMof K+ and did not corre-
late with an efflux of K+ (Figure 4G–4I). In sum, these results indi-
cate that K+ regulates the activation of the NLRP3 inflammasome
upstream of Asc; i.e., K+ efflux acts either on NLRP3 or upstream
of NLRP3.
The Formation of a Large Pore Is Not Required to
Activate NLRP3
We showed above that particulate matter share the ability with
pore-forming toxins to cause K+ efflux. However, it is unknown
whether a drop in cytosolic [K+] is sufficient to activate NLRP3
because ATP also induces the formation of a large unspecific
pore in the cell membrane that was suggested to be involved
in caspase-1 activation (Pelegrin and Surprenant, 2006). There-
fore, we determined whether permeation of the cell membrane
to moieties larger than K+ is a common feature among NLRP3
activators. Stimulation of BMDMswith nigericin and the bacterial
PFTs gramicidin, a-hemolysin, and aerolysin did not permit the
uptake of ethidium (molecular weight 314), as opposed to ATP
(Figure 5A). Strikingly, stimulation with particulate matter and
LL-OMe increased ethidium uptake (Figure 5B). In contrast to
ATP, ethidium uptake triggered by particulate matter and LL-
OMe was unimpaired in P2rx7/ BMDM (Figure 5C). Further-
more, ethidium uptake elicited by all stimuli was upstream to
NLRP3 as it was undiminished in Nlrp3/ BMDMs (Figure 5C).
Notably, inhibition of phagocytosis with cytochalasin B and
latrunculin B strongly reduced ethidium uptake triggered by par-
ticulate matter, but not by LL-OMe (Figure 5D).
Next, we analyzed whether NLRP3 activators can permeate
the cell membrane to the organic osmolyte taurine (molecular
mass of 125). Incubation of BMDMs in the presence of [3H]-
taurine revealed that BMDMs avidly incorporate the organic
osmolyte (Figure S3A). Bacterial PFTs and ATP elicited the efflux
of [3H]-taurine but, remarkably, nigericin did not (Figure 5E). [3H]-
taurine efflux occurred upstream of NLRP3 for all stimuli and
was independent of the P2rx7 for bacterial PFTs, but not for
ATP (Figure 5E). Consistent with their ability to elicit the uptake
of ethidium, particulate matter also triggered the efflux of the
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Figure 4. Cytosolic K+ Is a Specific
Upstream Regulator of the NLRP3 Inflam-
masome
(A) LPS-primed WT BMDMs were stimulated for
30 min with 10 mM nigericin (Nig), 0.5 mM grami-
cidin (Gra), 10 mg/ml S. aureus a-hemolysin (aH),
10 ng/ml A. hydrophila aerolysin (Aero), or 5 mM
ATP in medium containing the specified [K+], and
secreted IL-1b was measured.
(B) LPS-primed WT BMDMs were stimulated for
2 hr with 250 mg/ml of Al(OH)3, silica (SiO2) or
calcium pyrophosphate crystals (CPPD), or with
1 mM L-leucyl-L-leucine methyl ester (LL-OMe)
in medium containing the specified [K+], and
secreted IL-1b was measured.
(C and D) LPS-primed WT, Asc/, and Nlrp3/
BMDMs were stimulated with 5 mg/ml pdAdT
for 4 hr or 0.5 mM gramicidin (Gra) for 30 min,
and the release of IL-1b (C) and the intra-
cellular content of K+ (D) were measured. K+
determinations were performed in Asc/
macrophages.
(E) LPS-primed WT and Asc/ BMDMs were
treated with 5 mg/ml pdAdT for 4 hr or 0.5 mM
gramicidin (Gra) for 30 min in medium containing
5 or 45 mM K+, and IL-1b was quantified in the
supernatants.
(F) LPS-primed WT BMDMs were stimulated
30 min with 0.5 mM gramicidin (Gra) in medium
containing 5 or 45 mM K+. The cells were
lysed with 1% NP-40 and separated by cen-
trifugation in supernatants and pellets. Proteins in
cell pellets and supernatants were crosslinked
with DSS and immunoblotted with anti-Asc
antibody.
(G and H) BMDM from WT and Nlrp3R258W mice
were stimulated as indicated for 4 hr (0.5 mg/ml
LPS, 100 mM YVAD) and released IL-1b (G), and
caspase-1 activation (H) were analyzed.
(I) BMDMs fromNlrp3R258Wmice were treated with
0.5 mg/ml LPS or vehicle for 4 hr, and the intra-
cellular content of K+ was determined. IL-1b was
measured by ELISA, caspase-1 activation by
immunoblotting and intracellular K+ by ICP-OES. In experiments with high K+ medium, the osmolarity was maintained at 300 mOsm by isosmotic substitution
of NaCl with KCl. Values represent mean ± SD (n = 3). Results are representative of at least three separate experiments.
Immunity
K+ Efflux Activates NLRP3smaller molecule [3H]-taurine, which was detectable as early as
30 min after stimulation (Figure S3B) and strongly impaired by
the phagocytosis inhibitors cytochalasin B and latrunculin B (Fig-
ure S3C). These results demonstrate that membrane permeation
to chemical species larger than K+ is commonly caused by
NLRP3 activators because eight out of the nine agonists tested
permeated the cell membrane to [3H]-taurine and/or ethidium
(Figure 5E; Figure S3B). However, NLRP3 activation is unlikely
to be triggered by the formation of a large nonselective pore as
previously suggested (Pelegrin and Surprenant, 2006), because
nigericin activates NLRP3 without permeating the cell to the
small metabolite taurine (Figure 5E).
NLRP3 Activation Correlates with Efflux of K+ and the
Influx of Na+ but Not with the Permeation to Cl–
To better define the minimal membrane permeation events
required to activate NLRP3, we investigated whether NLRP3
activation requires increased cell membrane permeability to
Na+ and Cl ions. Treatment of BMDMs with gramicidin causedan increase in the intracellular levels of both Na+ and Cl in addi-
tion to a decrease in the intracellular content of K+ (Figure 5F).
Nigericin only caused a decrease in intracellular K+ and an in-
crease in intracellular Na+ but did not produce a change in Cl
concentrations (Figure 5F). Hence, NLRP3 activation correlates
with the efflux of K+ and the influx of Na+, but not with Cl fluxes.
K+-Free Medium Alone Activates the NLRP3
Inflammasome
To further evaluate the role of K+ in NLRP3 activation, we tested
whether decreasing the intracellular content of K+ by incubating
the cells in low-K+ media is sufficient to activate the NLRP3
inflammasome. We examined this hypothesis by using two
different approaches. First, we incubated BMDMs from wild-
type (WT) and Nlrp3/ mice in medium containing 5 mM or
0mMK+ and analyzed the secretion of IL-1b and the intracellular
content of K+ at different time points. When macrophages were
incubated in K+-free medium, IL-1b secretion was detected as
early as 30 min in the absence of any stimuli and correlatedImmunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc. 1147
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Figure 5. NLRP3 Activation Correlates with
K+ Efflux and Na+ Influx but Not with the
Opening of a Nonselective Pore
(A) Ethidium uptake kinetics in BMDMs treated
with 10 mM nigericin (Nig), 0.5 mM gramicidin (Gra),
10 mg/ml S. aureus a-hemolysin (aH), 10 ng/ml
A. hydrophila aerolysin (Aero), or 5 mM ATP. The
total increase of ethidium fluorescence during the
stimulation (DF ethidium) is shown in the right
panel.
(B) Ethidium uptake kinetics in BMDMs treated
with 250 mg/ml of Al(OH)3, silica (SiO2) or calcium
pyrophosphate crystals (CPPD), or with 1 mM
L-leucyl-L-leucine methyl ester (LL-OMe) for 2 hr.
(C) WT, Nlrp3/, and P2rx7/ BMDMs were
stimulated for 2 hr with 250 mg/ml of Al(OH)3, silica
(SiO2), CPPD crystals, and 1 mM LL-OMe, and the
ethidium uptake was quantitated. ATP (5 mM,
30 min) was used as a control for P2rx7 signaling.
(D) Ethidium uptake by BMDMs stimulated for 2 hr
with 250 mg/ml Al(OH)3, silica (SiO2), CPPD crys-
tals, and 1 mM LL-OMe in the presence of
phagocytosis inhibitors cytochalasin B (5 mM,
Cyt B) and latrunculin B (200 nM, Lat B).
(E) [3H]-taurine efflux was determined in WT,
Nlrp3/, and P2rx7/ BMDMs treated 30 min
with 10 mM nigericin (Nig), 0.5 mM gramicidin (Gra),
10 mg/ml S. aureus a-hemolysin (aH), 10 ng/ml
A. hydrophila aerolysin (Aero), or 5 mM ATP.
(F) The intracellular content of K+, Na+, and Cl
was determined in BMDMs treated 30 min with
10 mM nigericin (Nig) or 0.5 mM gramicidin (Gra).
Na+ and K+ were measured by ICP-OES and Cl
by ICP-MS in Nlrp3/ cells. Values represent
mean ± SD (n = 3). Results are representative of
at least three separate experiments. FU, fluores-
cence units. See also Figure S3.
Immunity
K+ Efflux Activates NLRP3with an intracellular content of K+ % 74% ± 1.34% (average ±
SEM of three independent experiments) (Figure 6A). In a second
approach, we incubated BMDMs for 2 hr in media containing
decreasing [K+] and measured the secretion of IL-1b, caspase-1
activation, and the intracellular content of K+ (Figure 6B). Under
these conditions, IL-1b secretion in WT BMDMs was only
detected when the extracellular [K+] was %0.5 mM and corre-
lated with an intracellular content of K+ of % 77% ± 1.25%
(average ± SEM of three independent experiments) (Figure 6B).
These results demonstrate that incubating BMDMs in low-K+
medium is sufficient to activate NLRP3 in the absence of an
NLRP3 agonist. Furthermore, our results indicate that the
threshold of intracellular K+ to engage NLRP3 is in the range of
70%–80%. The Na+/K+-ATPase inhibitor ouabain enhanced
NLRP3 activation induced by K+-free medium, and at higher
doses it was sufficient to activate NLRP3 (Figure 6C).
Compan et al. proposed that a regulatory volume decrease
(RVD) following cell swelling is necessary in addition to K+ efflux
to activate NLRP3 (Compan et al., 2012). However, the latter ex-
periments were performed by diluting isotonic medium with
distilled water and therefore did not consider the effect of
reducing the extracellular [K+] in NLRP3 activation. Thus, we
analyzed the individual contribution of lowering the osmolarity
and the extracellular concentration of K+ to NLRP3 activation.
Notably, only incubation of macrophages in highly hypotonic
medium (90 mOsm) activated the NLRP3 inflammasome (Fig-1148 Immunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc.ure S4A), which correlated with nonspecific membrane perme-
ation and significant cellular toxicity as evidenced by increased
LDH release and a drop in ATP levels (Figure S4B). 90 mOsm
medium produced robust NLRP3 activation only when the extra-
cellular [K+] was below 5 mM (Figure S4A). Increasing the extra-
cellular [K+] prevented NLRP3 activation, but did not decrease
cytotoxicity, further suggesting that K+ efflux and not cytotoxicity
resulted in NLRP3 activation (Figure S4B). Furthermore, incuba-
tion of macrophages in 150–230 mOsm medium induced signif-
icant cell swelling (Figure S4D) and a RVD response (Figures
S4C) but did not activate NLRP3 (Figure S4A). Notably, K+-free
medium activates NLRP3 (Figures 6A and 6B) without causing
cell swelling (Figure S4E) and a RVD (Figure S4C). Collectively,
these results suggest that K+-free medium activates NLRP3
without swelling the cells. Furthermore, cell swelling or RVD
does not activate NLRP3, and NLRP3 activation by severe
hypo-osmolarity is largely due to the efflux of K+. In another
study, Lee et al. reported that a decrease in cAMP leads to
NLRP3 activation (Lee et al., 2012). However, we could not
detect a decrease in the cAMP levels upon stimulation with
K+-free medium (Figure S4F).
Na+ Influx Is Not an Absolute Requirement for NLRP3
Activation
We next evaluated the role of Na+ influx in NLRP3 activation
by iso-osmotically substituting extracellular Na+ by the cation
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Figure 6. Incubation in Low-K+ Medium Is
Sufficient to Activate NLRP3
(A) LPS-primed WT and Nlrp3/ BMDMs were
incubated in K+-free medium, and the release of
IL-1b (bars) and intracellular content of K+ (solid
squares) were measured at the specified time
points.
(B) LPS-primed WT and Nlrp3/ BMDMs were
incubated for 2 hr in medium containing the
specified [K+], and the release of IL-1b (bars) and
intracellular content of K+ (solid squares) were
measured.
(C) LPS-primed WT and Nlrp3/ BMDMs were
treated with ouabain for 2 hr in IMDM or K+-free
medium, and the release of IL-1b and the
intracellular content of K+ were determined.
IL-1b secretion was analyzed by ELISA. K+
determinations were performed in Nlrp3/ cells
by ICP-OES. Values represent mean ± SD (n = 3). *,
statistically significant (p < 0.05, WT versus
Nlrp3/). Results are representative of at least
three separate experiments. See also Figure S4.
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K+ Efflux Activates NLRP3choline. Remarkably, reducing the extracellular [Na+] had a
strong dose-dependent inhibitory effect on NLRP3 activation
induced by K+-free medium, gramicidin, or nigericin (Figures
7A and 7B; Figure S5A). These stimuli required an extracellular
[Na+]R 40, 15, and 40mM, respectively, to activate NLRP3 (Fig-
ures 7A and 7B; Figure S5A). Furthermore, lowering the extracel-
lular [Na+] also reduced the drop in the intracellular K+ caused by
all three stimuli (Figures 7A and B; Figure S5A). None of these
stimuli activated NLRP3 in medium containing 5mMNa+ despite
the fact that all of them induced a reduction in the intracellular
content of K+ below 60% (Figures 7A and 7B; Figure S5A).
Indeed, lowering the extracellular [Na+] decreased the K+
threshold for NLRP3 activation induced by low-K+ medium
from 70%–80% (Figures 6A and 6B) to 50%–60% (Figures 7A
and 7B; Figure S5A). These results suggest that Na+ influx can
modulate NLRP3 activation independently of K+ efflux. However,
substitution of extracellular Na+ with choline did not impair K+
efflux or NLRP3 activation elicited by ATP (Figure 7C), aerolysin,
Al(OH)3 and silica (Figure 7D; Figures S5B and S5C). Thus, our
results demonstrate that Na+ influx can modulate NLRP3 activa-
tion by certain agonists, but it is not a strict requirement for
NLRP3 activation. To further assess a role for Na+ in NLRP3 acti-
vation, we testedwhether the influx of Na+ is sufficient to activate
NLRP3. Treatment of BMDMs with doses of the Na+ ionophore
monensin previously shown to cause significant Na+ influx (Gur-
cel et al., 2006) did not cause NLRP3 activation (Figure S5C).
Next, we addressed a possible role of membrane depolarization
in NLRP3 activation. Gramicidin forms pores in the cell mem-
brane that allow K+ efflux and Na+ influx leading to membrane
depolarization in high-Na+ medium (Chifflet et al., 2004). How-Immunity 38, 1142–115ever, K+ efflux with decreased Na+ influx
leads to hyperpolarization (Blaustein and
Goldring, 1975; Langheinrich and Daut,
1997). To test whether membrane depo-
larization is required for NLRP3 activa-
tion, we treated the cells with gramicidin
in K+-free medium in which Na+ wassubstituted by the membrane impermeable cation choline (Fig-
ure S5D). Under these hyperpolarizing conditions (Blaustein
and Goldring, 1975; Langheinrich and Daut, 1997), gramicidin
caused robust caspase-1 activation (Figure S5D). These results
indicate that membrane depolarization is not required for NLRP3
activation and further support K+ efflux as the trigger of the
NLRP3 inflammasome.
DISCUSSION
The fact that NLRP3 is activated by an array of chemically and
structurally unrelated stimuli has led to the hypothesis that
NLRP3 does not directly detect these stimuli but instead senses
a commonly induced intracellular signal. In line with this notion,
several intracellular events have been proposed as the common
signal upstream to NLRP3, including a change in the intracellular
concentration of K+, the formation of a large pore in the cell mem-
brane, lysosomal destabilization, mitochondrial damage, the
production of ROS, changes in cell volume, and Ca2+ signaling.
The elucidation of the mechanism of NLRP3 activation is further
complicated by the pleiotropic action of NLRP3 agonists. For
example, ATP permeates the cell membrane to molecules up
to 900 Da, damages lysosomes and the mitochondria, and in-
creases the production of ROS. In this manuscript, we have
analyzed the cellular events that have been proposed to serve
as the common conduit to activate the NLRP3 inflammasome
by using a panel of stimuli. Our work indicates that intracellular
K+ depletion alone acting on or upstream of NLRP3 is the mini-
mal common cellular event that is necessary and sufficient to
activate the NLRP3 inflammasome.3, June 27, 2013 ª2013 Elsevier Inc. 1149
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Figure 7. Na+ Influx Can Modulate NLRP3 but
Is Not a Strict Requirement for Inflammasome
Activation
(A) LPS-primed WT and Nlrp3/ BMDMs were
incubated for 3 hr in K+-free medium containing the
specified [Na+], and the release of IL-1b (bars) and
the intracellular content of K+ (solid squares) were
measured.
(B and C) LPS-primed WT and Nlrp3/ BMDMs
were stimulated for 45 min with 0.5 mM gramicidin
(Gra) (B) or 5 mM ATP (C) in media containing 5 mM
K+ and the specified [Na+]. The release of IL-1b
(bars), the intracellular content of K+ (solid squares),
and caspase-1 activation were analyzed.
(D) LPS-primed WT BMDMs were stimulated for
45 min with 0.5 mM gramicidin (Gra) or 10 ng/ml
aerolysin (Aero) or for 3 hr with 250 mg/ml Al(OH)3 or
silica (SiO2) in medium containing 5mMK
+ and either
140 or 5 mM Na+, and caspase-1 activation was
analyzed. In low Na+ medium, NaCl was isosmoti-
cally substituted with choline chloride to maintain a
final osmolarity of 300 mOsm. IL-1b was measured
by ELISA and caspase-1 activation by immunoblot-
ting. K+ determinations were performed in Nlrp3/
cells by ICP-OES. Values represent mean ± SD
(n = 3). Results are representative of at least three
separate experiments. *, statistically significant (p <
0.05, WT versus Nlrp3/). See also Figure S5.
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K+ Efflux Activates NLRP3Mitochondrial damage has been suggested to be the up-
stream signal responsible for NLRP3 activation (Zhou et al.,
2011), and cells treated with nigericin and ATP were found to
have decreased OCR after 30–60 min of stimulation (Shimada
et al., 2012). Unlike this study, we found that nigericin, grami-
cidin, and ATP caused a rapid increase in the OCR. Robust
NLRP3 activation by nigericin, gramicidin, and ATP occurs within
30 min of stimulation. Therefore, it is possible that the mitochon-
drial damage in response to nigericin and ATP observed by Shi-
mada et al. (2012) at later time points is due to cytotoxic effects
of these stimuli and not involved in triggering NLRP3 activation.
We found that the rapid increase in OCR and ECAR elicited by
gramicidin was mediated by activation of the Na+/K+-ATPase
andwas unrelated to the activation of the NLRP3 inflammasome.
Although gramicidin can damage the mitochondria after
prolonged stimulation, we found conditions in which robust
NLRP3 activation was observed in the absence of mitochondrial1150 Immunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc.perturbation. Collectively, these results
indicate that although gramicidin can alter
the mitochondrial function through different
mechanisms, these effects are not required
for NLRP3 activation.
ROS generation secondary to mitochon-
drial damage has also been implicated in
NLRP3 activation because manipulation
of the respiratory chain with chemical
inhibitors was reported to trigger NLRP3
activation (Zhou et al., 2011). However, un-
like this study, we could not detect NLRP3
activation in cells treated with the mito-
chondrial toxicants rotenone and antimycin
A at maximally effective doses or with theautophagy inhibitor 3-MA or H2O2. We do not have an explana-
tion to account for the difference in results. High concentrations
of ROS inhibitors block NF-kB-mediated priming of the NLRP3
inflammasome, but not NLRP3 activation induced by nigericin
and silica (Bauernfeind et al., 2011). By using lower concentra-
tions of ROS scavengers that had a strong inhibitory effect on
the cellular redox state, we could not see an inhibitory effect
in either priming or NLRP3 activation. Thus, our results suggest
that ROS generation does not play a crucial role in NLRP3
activation.
Pioneering studies proposed that the efflux of K+ is respon-
sible for the maturation of pro-IL-1b because ATP and nigericin
permeate the cell membrane to K+ and high extracellular K+ pre-
vents pro-IL-1b processing (Perregaux and Gabel, 1994). Sub-
sequent studies further supported the hypothesis that NLRP3
activation by all tested stimuli is inhibited by high extracellular
[K+] (Pe´trilli et al., 2007). However, the role of K+ in NLRP3
Immunity
K+ Efflux Activates NLRP3activation by particulate matter has been questioned because,
to date, there is no experimental evidence that K+ efflux occurs
during stimulation with particulate matter (Tschopp and
Schroder, 2010). Furthermore, a recent report suggested that
particulate matter and soluble agonists activate NLRP3 through
two distinct mechanisms (Shenoy et al., 2012). Notably, we
found that K+ efflux precedes the activation of NLRP3 induced
by particulate matter and the lysosomal damaging dipeptide
LL-OMe. In addition, we found that NLRP3 activation by high
extracellular Ca2+ is due to K+ efflux and could be explained
by the formation of particulate matter. Therefore, our work
supports a unifying model for NLRP3 activation by membrane
permeating molecules and particulate matter in which a
decrease in the cytosolic concentration of K+ engages the
NLRP3 inflammasome. These results suggest that the internal-
ization of particulate matter via phagocytosis induces lysosomal
membrane damage, which triggers the opening of one or more
membrane pores permeable to K+.
It has also been proposed that the opening of an unspecific
pore formed by the hemichannel pannexin-1 after P2rx7 stim-
ulation by ATP or a RVD response is necessary for NLRP3 acti-
vation in addition to K+ efflux (Compan et al., 2012; Pelegrin
and Surprenant, 2006). However, recent studies using BMDMs
deficient in pannexin-1 showed that this hemichannel is not the
molecular substrate of the large pore opened by ATP (Qu et al.,
2011). To clarify the role of a large pore in NLRP3 activation, we
studied membrane permeation caused by NLRP3 activators to
a set of molecular markers of decreasing size: ethidium, [3H]-
taurine, Cl, and Na+. ATP, particulate matter, and LL-OMe
caused membrane permeation to K+ and the larger chemical
species [3H]-taurine and ethidium. Membrane permeation to
[3H]-taurine and ethidium by particulate matter was not medi-
ated by the P2rx7 and was secondary to phagocytosis
because it was strongly inhibited by cytochalasin B and latrun-
culin B. In contrast, the bacterial PFTs gramicidin, a-hemolysin,
and aerolysin did not permeabilize the cell membrane to
ethidium but caused the efflux of the smaller marker [3H]-
taurine. However, the H+/K+-ionophore nigericin caused the
efflux of K+ and the influx of Na+ but did not permeabilize the
cell membrane to Cl, [3H]-taurine, or ethidium. Therefore,
the minimal membrane permeabilization events associated
with NLRP3 activation are the efflux of K+ and the influx of
Na+. Depletion of intracellular K+ by incubating the cells in
low K+ medium was sufficient to activate NLRP3, which
occurred when the intracellular content of K+ dropped below
80%. In addition, K+-free medium activated NLRP3 without
causing a change in cell volume or a RVD response. It was
suggested that K+ efflux might not be sufficient to activate
NLRP3 because decreasing extracellular Na+ prevents NLRP3
activation (Perregaux and Gabel, 1998). Accordingly, substitut-
ing of extracellular Na+ by the cation choline had a strong
inhibitory effect in NLRP3 activation by K+-free medium, niger-
icin, and gramicidin. However, NLRP3 activation by ATP, aero-
lysin, Al(OH)3, and silica did not require extracellular Na
+.
Therefore, although all NLRP3 activators tested permeabilized
the cell membrane to Na+, the influx of Na+ or membrane de-
polarization was not an absolute requirement for NLRP3 activa-
tion. Thus, our results demonstrate that a drop in the cytosolic
content of K+ acts as the common signal triggered by bacterialPFTs and particulate matter, which is sufficient to engage the
NLRP3 inflammasome.
EXPERIMENTAL PROCEDURES
Elemental Analysis
Intracellular K+ andNa+measurementswere performed by inductively coupled
plasma optical emission spectrometry (ICP-OES) with a PerkinElmer Optima
2000 DV spectrometer using yttrium as internal standard. 35Cl was measured
by inductively coupled plasmamass spectrometry (ICP-MS) at theW. M. Keck
Elemental Geochemistry laboratory (University ofMichigan). The culturemedia
were thoroughly aspirated, and cells were extracted after 30 min in 3% ultra-
pure HNO3. K
+ determinations were done in 96-well plates. When K+, Na+, and
Cl were simultaneously analyzed, 12-well plates were used. For accurate
measurement of the intracellular ions, a control was performed in every exper-
iment to determine the extracellular amount of the investigated ion remaining
after aspiration, and this value was subtracted from every measurement. Also
for accurate elemental determinations, analyses were performed in inflamma-
some-deficient cells to avoid ion fluxes due to unspecific membrane perme-
ation secondary to pyroptosis. In experiments using low extracellular K+
and/or Na+, cells were washed with medium low in the respective ion prior
to stimulation to avoid ion carryover.
Metabolic Analysis
Oxygen consumption rate and extracellular acidification rate were measured
by using an XF24 Extracellular Flux Analyzer (Seahorse Bioscience). BMDMs
were seeded in 24-well plates (1.25 3 105/well). The following day, cells
were changed to bicarbonate-free DMEM and incubated in a non-CO2 incu-
bator for 1 hr before the experiment. Mix, wait, and measure times were 3,
2, and 3min, respectively. Valueswere obtained from the average of four wells.
Lactate was measured on the Siemen’s Advia 2400 autoanalyzer by using a
lactate oxidase colorimetric method. Intracellular ATP was measured by using
the CellTiter-Glo Luminescent Cell Viability Assay (Promega).
[3H]-Taurine Release
BMDMs were seeded in 96-well plates, and 6 hours later the medium was re-
placed by 100 ml of medium containing 0.5 mCi/ml of [1,2-3H]-taurine. The
following day, the cells were washed three times with PBS and stimulated.
The stimulations were terminated by rapid aspiration of the medium, and cells
were lysed with 6% trichloroacetic acid. Taurine efflux was calculated as a
fractional release; i.e., the radioactivity released into the extracellular medium
as a percentage of the total radioactivity present initially in the cells. The latter
was calculated as the sum of radioactivity recovered in the supernatant and
that remaining in the cells at the end of the assay. Cell volume measurements
were performed with a Coulter Counter (Beckman).
SUPPLEMENTAL INFORMATION
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org/10.1016/j.immuni.2013.05.016.
ACKNOWLEDGMENTS
The studies were supported by National Institutes of Health (NIH) grants
AI06333, DK091191, and AR059688 (to G.N.). Bioenergetics studies were
done at the Molecular Phenotyping Core, supported by the Michigan Nutrition
Obesity Research Center (NIH grant DK089503). G.M.-C. was supported by
the postbaccalaureate Research Education Program grant 5 R25 GM086262
from the NIH. We thank Millenium Pharmaceuticals, George Dubyak, Eicke
Latz, and Warren Strober for generously supplying mutant mice, Yuumi Naka-
mura for maintaining the Nlrp3R258W knockin colony, Stephen Fisher for help
with [3H]-taurine experiments, Grace Chen and Luigi Franchi for critical review
of this manuscript, Joel Whitfield for ELISA measurements, Sherry Koonse for
animal husbandry, Sydney Bridges for performing Seahorse experiments, Ted
Huston for ICP-MS measurements, Keith Matz for lactate measurements, and
James Windak for ICP-OES technical support.Immunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc. 1151
Immunity
K+ Efflux Activates NLRP3Received: May 24, 2012
Accepted: May 20, 2013
Published: June 27, 2013
REFERENCES
Allam, R., Darisipudi, M.N., Rupanagudi, K.V., Lichtnekert, J., Tschopp, J., and
Anders, H.J. (2011). Cutting edge: cyclic polypeptide and aminoglycoside
antibiotics trigger IL-1b secretion by activating the NLRP3 inflammasome.
J. Immunol. 186, 2714–2718.
Andersen, O.S., Koeppe, R.E., 2nd, and Roux, B. (2005). Gramicidin channels.
IEEE Trans. Nanobioscience 4, 10–20.
Bauernfeind, F.G., Horvath, G., Stutz, A., Alnemri, E.S., MacDonald, K.,
Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B.G., Fitzgerald, K.A.,
et al. (2009). Cutting edge: NF-kappaB activating pattern recognition and cyto-
kine receptors license NLRP3 inflammasome activation by regulating NLRP3
expression. J. Immunol. 183, 787–791.
Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Nu´n˜ez, G., and Hornung,
V. (2011). Cutting edge: reactive oxygen species inhibitors block
priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 187,
613–617.
Blaustein, M.P., and Goldring, J.M. (1975). Membrane potentials in pinched-
off presynaptic nerve ternimals monitored with a fluorescent probe: evidence
that synaptosomes have potassium diffusion potentials. J. Physiol. 247,
589–615.
Chen, Y.J., Hsieh, M.Y., Chang, M.Y., Chen, H.C., Jan, M.S., Maa, M.C., and
Leu, T.H. (2012). Eps8 protein facilitates phagocytosis by increasing TLR4-
MyD88 protein interaction in lipopolysaccharide-stimulated macrophages.
J. Biol. Chem. 287, 18806–18819.
Chifflet, S., Correa, V., Nin, V., Justet, C., and Herna´ndez, J.A. (2004). Effect of
membrane potential depolarization on the organization of the actin cytoskel-
eton of eye epithelia. The role of adherens junctions. Exp. Eye Res. 79,
769–777.
Compan, V., Baroja-Mazo, A., Lo´pez-Castejo´n, G., Gomez, A.I., Martı´nez,
C.M., Angosto, D., Montero, M.T., Herranz, A.S., Baza´n, E., Reimers, D.,
et al. (2012). Cell volume regulation modulates NLRP3 inflammasome activa-
tion. Immunity 37, 487–500.
Cruz, C.M., Rinna, A., Forman, H.J., Ventura, A.L., Persechini, P.M., and
Ojcius, D.M. (2007). ATP activates a reactive oxygen species-dependent
oxidative stress response and secretion of proinflammatory cytokines in mac-
rophages. J. Biol. Chem. 282, 2871–2879.
Decleva, E., Menegazzi, R., Busetto, S., Patriarca, P., and Dri, P. (2006).
Common methodology is inadequate for studies on the microbicidal activity
of neutrophils. J. Leukoc. Biol. 79, 87–94.
Fernandes-Alnemri, T., Yu, J.-W., Juliana, C., Solorzano, L., Kang, S., Wu, J.,
Datta, P., McCormick, M., Huang, L., McDermott, E., et al. (2010). The AIM2
inflammasome is critical for innate immunity to Francisella tularensis. Nat.
Immunol. 11, 385–393.
Franchi, L., Eigenbrod, T., and Nu´n˜ez, G. (2009). Cutting edge: TNF-alpha
mediates sensitization to ATP and silica via the NLRP3 inflammasome in the
absence of microbial stimulation. J. Immunol. 183, 792–796.
Franchi, L., Mun˜oz-Planillo, R., and Nu´n˜ez, G. (2012). Sensing and reacting to
microbes through the inflammasomes. Nat. Immunol. 13, 325–332.
Guicciardi, M.E., Leist, M., and Gores, G.J. (2004). Lysosomes in cell death.
Oncogene 23, 2881–2890.
Gurcel, L., Abrami, L., Girardin, S., Tschopp, J., and van der Goot, F.G. (2006).
Caspase-1 activation of lipid metabolic pathways in response to bacterial
pore-forming toxins promotes cell survival. Cell 126, 1135–1145.
Hoffman, H.M., Mueller, J.L., Broide, D.H.,Wanderer, A.A., and Kolodner, R.D.
(2001). Mutation of a new gene encoding a putative pyrin-like protein causes
familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat.
Genet. 29, 301–305.
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L.,
Fitzgerald, K.A., and Latz, E. (2008). Silica crystals and aluminum salts activate1152 Immunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc.the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol.
9, 847–856.
Jin, C., Frayssinet, P., Pelker, R., Cwirka, D., Hu, B., Vignery, A., Eisenbarth,
S.C., and Flavell, R.A. (2011). NLRP3 inflammasome plays a critical role in
the pathogenesis of hydroxyapatite-associated arthropathy. Proc. Natl.
Acad. Sci. USA 108, 14867–14872.
Juliana, C., Fernandes-Alnemri, T., Wu, J., Datta, P., Solorzano, L., Yu, J.W.,
Meng, R., Quong, A.A., Latz, E., Scott, C.P., and Alnemri, E.S. (2010). Anti-
inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors
of the inflammasome. J. Biol. Chem. 285, 9792–9802.
Langheinrich, U., and Daut, J. (1997). Hyperpolarization of isolated capillaries
from guinea-pig heart induced by K+ channel openers and glucose depriva-
tion. J. Physiol. 502, 397–408.
Lee, G.S., Subramanian, N., Kim, A.I., Aksentijevich, I., Goldbach-Mansky, R.,
Sacks, D.B., Germain, R.N., Kastner, D.L., and Chae, J.J. (2012). The calcium-
sensing receptor regulates the NLRP3 inflammasome through Ca2+ and
cAMP. Nature 492, 123–127.
Lopez-Castejon, G., Theaker, J., Pelegrin, P., Clifton, A.D., Braddock, M., and
Surprenant, A. (2010). P2X(7) receptor-mediated release of cathepsins from
macrophages is a cytokine-independent mechanism potentially involved in
joint diseases. J. Immunol. 185, 2611–2619.
Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee,
W.P., Roose-Girma, M., Erickson, S., and Dixit, V.M. (2004). Differential activa-
tion of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430,
213–218.
Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O’Rourke, K., Roose-
Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M., and Dixit, V.M. (2006).
Cryopyrin activates the inflammasome in response to toxins and ATP.
Nature 440, 228–232.
Martinon, F., Pe´trilli, V., Mayor, A., Tardivel, A., and Tschopp, J. (2006). Gout-
associated uric acid crystals activate the NALP3 inflammasome. Nature 440,
237–241.
Meng, G., Zhang, F., Fuss, I., Kitani, A., and Strober, W. (2009). A mutation in
the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-
dominant immune responses. Immunity 30, 860–874.
Pelegrin, P., and Surprenant, A. (2006). Pannexin-1mediates large pore forma-
tion and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J.
25, 5071–5082.
Peppelenbosch, M.P., DeSmedt, M., ten Hove, T., van Deventer, S.J., and
Grooten, J. (1999). Lipopolysaccharide regulates macrophage fluid phase
pinocytosis via CD14-dependent and CD14-independent pathways. Blood
93, 4011–4018.
Perregaux, D., and Gabel, C.A. (1994). Interleukin-1 beta maturation and
release in response to ATP and nigericin. Evidence that potassium depletion
mediated by these agents is a necessary and common feature of their activity.
J. Biol. Chem. 269, 15195–15203.
Perregaux, D.G., and Gabel, C.A. (1998). Human monocyte stimulus-coupled
IL-1beta posttranslational processing: modulation via monovalent cations.
Am. J. Physiol. 275, C1538–C1547.
Pe´trilli, V., Papin, S., Dostert, C., Mayor, A., Martinon, F., and Tschopp, J.
(2007). Activation of the NALP3 inflammasome is triggered by low intracellular
potassium concentration. Cell Death Differ. 14, 1583–1589.
Qu, Y., Misaghi, S., Newton, K., Gilmour, L.L., Louie, S., Cupp, J.E., Dubyak,
G.R., Hackos, D., andDixit, V.M. (2011). Pannexin-1 is required for ATP release
during apoptosis but not for inflammasome activation. J. Immunol. 186, 6553–
6561.
Rose, C.R., and Ransom, B.R. (1997). Regulation of intracellular sodium in
cultured rat hippocampal neurones. J. Physiol. 499, 573–587.
Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140, 821–832.
Shenoy, A.R., Wellington, D.A., Kumar, P., Kassa, H., Booth, C.J., Cresswell,
P., and MacMicking, J.D. (2012). GBP5 promotes NLRP3 inflammasome
assembly and immunity in mammals. Science 336, 481–485.
Shimada, K., Crother, T.R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S.,
Ramanujan, V.K., Wolf, A.J., Vergnes, L., Ojcius, D.M., et al. (2012). Oxidized
Immunity
K+ Efflux Activates NLRP3mitochondrial DNA activates the NLRP3 inflammasome during apoptosis.
Immunity 36, 401–414.
Steinberg, T.H., Newman, A.S., Swanson, J.A., and Silverstein, S.C. (1987).
ATP4- permeabilizes the plasma membrane of mouse macrophages to fluo-
rescent dyes. J. Biol. Chem. 262, 8884–8888.
Surprenant, A., Rassendren, F., Kawashima, E., North, R.A., and Buell, G.
(1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X re-
ceptor (P2X7). Science 272, 735–738.Tschopp, J., and Schroder, K. (2010). NLRP3 inflammasome activation: The
convergence of multiple signalling pathways on ROS production? Nat. Rev.
Immunol. 10, 210–215.
Wen, H., Ting, J.P., and O’Neill, L.A. (2012). A role for the NLRP3 inflamma-
some in metabolic diseases—did Warburg miss inflammation? Nat.
Immunol. 13, 352–357.
Zhou, R., Yazdi, A.S., Menu, P., and Tschopp, J. (2011). A role formitochondria
in NLRP3 inflammasome activation. Nature 469, 221–225.Immunity 38, 1142–1153, June 27, 2013 ª2013 Elsevier Inc. 1153
